{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:11:27Z","timestamp":1783937487697,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.contraception.2016.05.016","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T06:30:33Z","timestamp":1465281033000},"page":"621-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Contraceptive safety among women with cystic fibrosis: a systematic review"],"prefix":"10.1016","volume":"94","author":[{"given":"Maura K.","family":"Whiteman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilope","family":"Oduyebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.05.016_bb0005","series-title":"Cystic Fibrosis Foundation Patient Registry annual data report, 2012","year":"2013"},{"key":"10.1016\/j.contraception.2016.05.016_bb0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ppul.22967","article-title":"The cystic fibrosis gender gap: potential roles of estrogen","volume":"49","author":"Sweezey","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.contraception.2016.05.016_bb0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.prrv.2012.03.005","article-title":"Cystic fibrosis: what to expect now in the early adult years","volume":"13","author":"Quon","year":"2012","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.contraception.2016.05.016_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2015.07.007","article-title":"Contraception in women with cystic fibrosis: a systematic review of the literature","volume":"93","author":"Roe","year":"2016","journal-title":"Contraception"},{"issue":"RR-4","key":"10.1016\/j.contraception.2016.05.016_bb0025","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.05.016_bb0030","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.05.016_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2016.05.016_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1183\/09031936.00018712","article-title":"Oral contraceptives do not appear to affect cystic fibrosis disease severity","volume":"41","author":"Kernan","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.contraception.2016.05.016_bb0045","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMoa1106126","article-title":"Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis","volume":"366","author":"Chotirmall","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2016.05.016_bb0050","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1378\/chest.86.6.863","article-title":"Use of oral contraceptives in women with cystic fibrosis","volume":"86","author":"Fitzpatrick","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.contraception.2016.05.016_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/thx.42.1.59","article-title":"Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis","volume":"42","author":"Stead","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.contraception.2016.05.016_bb0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcf.2008.03.001","article-title":"Contraceptive practices in women with cystic fibrosis","volume":"7","author":"Plant","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.contraception.2016.05.016_bb0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<244::AID-PPUL16>3.0.CO;2-#","article-title":"Role of progestational agents in the treatment of undernourished patients with cystic fibrosis","volume":"29","author":"Kissner","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.contraception.2016.05.016_bb0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jfprhc-2013-100783","article-title":"Hormonal contraception in female lung transplant recipients: a case series","volume":"40","author":"Bader","year":"2014","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.05.016_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02914541","article-title":"Pharmacokinetics of drugs in cystic fibrosis","volume":"9","author":"Spino","year":"1991","journal-title":"Clin Rev Allergy"},{"key":"10.1016\/j.contraception.2016.05.016_bb0080","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2016.05.016_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcf.2008.05.008","article-title":"Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)","volume":"7","author":"van den Berg","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.contraception.2016.05.016_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ppul.21566","article-title":"Venous thromboembolism in cystic fibrosis","volume":"47","author":"Takemoto","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.contraception.2016.05.016_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.contraception.2016.05.016_bb0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.016_bb0105","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2016.05.016_bb0110","series-title":"Orkambi [package insert]","year":"2016"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T04:32:31Z","timestamp":1656649951000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416301159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0010782416301159"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.05.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraceptive safety among women with cystic fibrosis: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.contraception.2016.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}